Becky Hollenberg

speaker

57 appearances 1 recordings 1 series first heard Jul 2026 last heard 13 Jul

Becky Hollenberg’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.

Appearances

newest first · ▶ plays the moment

tHEORetically Speaking · From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap · 13 Jul 2026 podcast

Yeah, so most real-world evidence is generated from fragmented data sources that, like you said, are only capturing parts of the patient journey.

So this can often answer who's receiving treatments, when did treatments occur, how much did treatments cost, but they struggle to answer kind of the why behind those questions.

So why was therapy initiated, why did patients discontinue, what clinical characteristics drove outcomes, how did payer restrictions impact access, and

which patients never received therapy despite clinical need.

So the root issue isn't the volume of the data, it's that it's fragmented.

So sources capture isolated pieces of the journey that aren't connected.

So our approach at Neurostella is integrating those data sources to kind of create a complete picture of the why behind the patient journey.

So that's linking the claims, the EMR, clinical notes, labs, and payer coverage and access data

on the payer level, and then rolling it up to whatever level the client needs.

Yeah, so I think the why is becoming more central for external stakeholders and internal teams.

They increasingly want evidence of real-world effectiveness, appropriate patient identification, outcome drivers, and impact of access restrictions.

There is a real risk there because incomplete evidence can lead to mischaracterized patient populations, biased outcomes, missing access barriers, and value stories that are only telling half the pictures, in some cases, telling the wrong story that's not really capturing what's truly happening to the patient when you connect everything together.

So in short, data access is no longer the differentiator.

The usability of the evidence and the applicability and generalizability of that evidence will be.

Yeah, so it's each source is kind of answering a different question about the patient journey.

So claims are going to really help ground into what happened and when.

EMR is going to show more of that patient status and vital side of it and lab values are going to show what's happening biologically.

The clinical notes is where we really see a lot of the depth unlocked in terms of things you wouldn't see typically in a structured data source.

So that could be anything from disease severity to treatment decision making, treatment rationale,

symptoms, clinical presentation that the patient's going through.

Showing 1–20 of 57 · page 1 of 3